Identification of novel small molecule activators of nuclear factor-κb with neuroprotective action via high-throughput screening-Reference-Cited by-同舟云学术

Identification of novel small molecule activators of nuclear factor-κb with neuroprotective action via high-throughput screening

Published:2010-11-02 Issue:1 Volume:89 Page:58-72
ISSN:0360-4012
Container-title:Journal of Neuroscience Research
language:en
Short-container-title:J. Neurosci. Res.

Author:

Manuvakhova Marina S.,Johnson Guyla G.,White Misti C.,Ananthan Subramaniam,Sosa Melinda,Maddox Clinton,McKellip Sara,Rasmussen Lynn,Wennerberg Krister,Hobrath Judith V.,White E. Lucile,Maddry Joseph A.,Grimaldi Maurizio

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jnr.22526/fullpdf

Reference39 articles.

1. Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity;Albensi;Synapse,2000

2. Transformation of chicken embryo fibroblasts by direct DNA transfection of single oncogenes: comparative analyses of src, erbB, myc, and ras;Antczak;J Virol,1990

3. Characterization of chemical libraries for luciferase inhibitory activity;Auld;J Med Chem,2008

4. The x-ray crystal structure of the NF-kappa B p50.p65 heterodimer bound to the interferon beta-kappa B site;Berkowitz;J Biol Chem,2002

5. Constitutive nuclear factor-kappa B activity is required for central neuron survival;Bhakar;J Neurosci,2002

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Graph Attention Network based mapping of knowledge relations between chemical spaces of Nuclear factor kappa B and Centella asiatica;Computational Biology and Chemistry;2023-12

2. Small molecules targeting different cellular pathologies for the treatment of amyotrophic lateral sclerosis;Medicinal Research Reviews;2023-05-26

3. The NRF2-Dependent Transcriptional Regulation of Antioxidant Defense Pathways: Relevance for Cell Type-Specific Vulnerability to Neurodegeneration and Therapeutic Intervention;Antioxidants;2021-12-21

4. Structure-activity relationship (SAR) studies of N-(3-methylpyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine (SRI-22819) as NF-ҡB activators for the treatment of ALS;European Journal of Medicinal Chemistry;2021-01

5. In vitro benchmarking of NF-κB inhibitors;European Journal of Pharmacology;2020-04